Catalyst Wire Dossier Catalyst Wire Dossier

Sofosbuvir (Sovaldi)

sofosbuvir · Gilead Sciences
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Sofosbuvir (Sovaldi), covering 2014-01-16 to 2015-03-06. Get the full timeline:

Most recent: Clinical Trial Update: Open-Label Safety Study of Telaprevir and Sofosbuvir in Chronic Hepatitis C Genotype 1 [Phase 2]

See pricing